Close
Nordic 9Nordic 9

Meneldor (investor - Venture Capital)

Netherlands meneldor.nl
See something wrong or missing? Let us know
Offices:Amsterdam

Meneldor is a biopharmaceutical investment company from the Netherlands.

Average round investment:23.12M USD
Average number per year:1.5
Distribution: 2023 (1)2022 (2)
Portfolio companies: Netherlands Tagworks PharmaceuticalsNorway Hemispherian
Mostly invests in: Norway Norway (2) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Meneldor

Name Criteria
Norway Sparebanken Vest
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
United States Asymmetry Ventures
72%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Norway CoFounder
72%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Apus Capital
71%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Kistefos
71%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Norway Stratel AS
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United Kingdom Laidlaw Scholars Ventures
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain Xesgalicia
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Poland Atmos Ventures
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Aurélien Barrière
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top